Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 13 of 23
Use of a Self-Directed Exercise Program (SDEP) Following Selected Lower Extremity Fractures
NCT04612478
Work Ability in Young Adult Cancer Survivors
NCT03148080
Efficacy of a Recreation Therapy Wellness Recovery Program for Individuals With Parkinson's Disease
NCT04164043
Pain Control in Colorectal Surgery: Liposomal Bupivacaine Block Versus Intravenous Lidociane
NCT04005859
Health Outcomes After Participating in Exercise (HOPE)
NCT03430115
Measuring Health Related Quality of Life in AYAs
NCT03482778
Improvisational Movement for People With Memory Loss and Their Caregivers
NCT03333837
The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems
NCT03716050
EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery
NCT03403192
LCI-GER-NOS-TAB-001: Tablet for Geriatric Assessment
NCT03419468
LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma
NCT03361306
Does Modified Ultrafiltration Affect Thromboelastography Results?
NCT03214120
Apneic Oxygenation in the Pediatric Intensive Care Unit
NCT03374046
Trauma Routing Algorithm for Pediatrics
NCT03359421
Cognitive Dysfunction and Breast Cancer Coping Strategies Impact on QOL
NCT03476226
Interactive Group Drumming (IGD) in Hospital Experience of Patients Undergoing Hematopoietic Stem Cell Transplant - A Pilot Study
NCT03345433
Healthy Living Partnerships to Prevent Diabetes in Veterans Pilot Study
NCT02835495
LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma
NCT03287947
Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin
NCT03296033
Rivanna Ultrasound for Neuraxial Block
NCT03214640
Brilliant Study: Assessing Cognition in Myeloma Patients Undergoing Transplant
NCT03355235
Mediterranean Diet and the Gut Microbiome
NCT03269032
Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD)
NCT03219866
Eucrisa for Atopic Dermatitis
NCT03250663
Food Security and Perceptions and Barriers to Healthy Eating in Individuals With Spinal Cord Injuries
NCT03457558
Correcting Platelet Dysfunction After Traumatic Brain Injury
NCT03182946
Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery
NCT03287089
Virtual Seating Coach on Power Wheelchairs of Persons With Amyotrophic Lateral Sclerosis (ALS)
NCT05742828
Pediatric Hypertension Registry (PHREG)
NCT03305562
Is Tau Protein Linked to Mobility Function?
NCT03430648
Harvoni Treatment Porphyria Cutanea Tarda
NCT03118674
Virtual Visits (Utilization of Virtual Care in Postoperative Patients to Improve the Patient Experience)
NCT03258177
Patient Management of Depression Through Technology: a Study of Digitally Enabled Engagement
NCT03242213
HELP Prevent Cancer Pilot Study
NCT02960542
Healthy Weight Poster, Multi-site Study
NCT03128112
TS Overexpression in SCLC: Mechanism and Therapeutic Targeting
NCT03741829
Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer
NCT03018080
An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD
NCT03207776
Evaluation of Behavioral Health-Virtual Patient Navigation Team (BH-VPN)
NCT03204643
Comparison of EVD Catheter Diameter on Occlusion and Replacement
NCT03248739
PECS Block: Plasma Bupivacaine Level
NCT03059498
Assessing Patient Confidence in Biologic Medications
NCT03168347
Postop Pain in the MICS Patients Versus Sternotomy Patients
NCT04003584
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil
NCT02822573
A Study Promoting Critical Illness Recovery in the Elderly
NCT02963558
Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer
NCT03032250
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer
NCT03139435
Prospective Evaluation of 14F Thal Tube vs 28 French Chest Tube for Hemothorax and Use of Maximum Barrier Precautions
NCT03167723
Utilizing Protein During Weight Loss to Impact Physical Function
NCT03074643
Utilizing Protein During Weight Loss to Impact Physical Function and Bone
NCT03819478
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.